Bioleaders Corporation announced a private placement of 5,000,000 common shares at an issue price of KRW 2,000 per share for the gross proceeds of KRW 10,000,000,000 on March 12, 2024. The transaction will include participation from new investor Moadata Co., Ltd. The transaction has been approved by the shareholders of the company and is expected to close on April 15, 2024. The shares are restricted to a hold period of 1 year.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,755 KRW | +5.96% | +8.68% | +14.55% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
3,830 KRW | +7.28% | +20.25% | 91.09M | ||
2,755 KRW | +5.96% | +8.68% | 69.17M | ||
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.55% | 69.17M | |
-4.68% | 10.83B | |
+13.64% | 1.99B | |
-31.78% | 332M | |
-2.56% | 102M |
- Stock Market
- Equities
- A288980 Stock
- News Moadata Co., Ltd.
- Bioleaders Corporation announced that it expects to receive KRW 10 billion in funding from Moadata Co., Ltd.